Evidence map›Paper›PMID 33494289›Full record

ArticleJournal of clinical medicine2021

Limiting the Use of Oral Glucose Tolerance Tests to Screen for Hyperglycemia in Pregnancy during Pandemics.

Charlotte Nachtergaele, Eric Vicaut, Sopio Tatulashvili, Sara Pinto, Hélène Bihan, Meriem Sal, Narimane Berkane, Lucie Allard, Camille Baudry, Jean-Jacques Portal and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Recent Advances in Gestational Diabetes Mellitus.Journal of clinical medicine · 2021
    Article
  8. An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Charlotte NachtergaeleAP-HP, Unité de Recherche Clinique St-Louis-Lariboisière, Université Denis Diderot, 75009 Paris, France.
Eric VicautAP-HP, Unité de Recherche Clinique St-Louis-Lariboisière, Université Denis Diderot, 75009 Paris, France.
Sopio TatulashviliAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.
Sara PintoAP-HP, Department of Endocrinology-Diabetology-Nutrition, Jean Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 143 Bondy, France.
Hélène BihanAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.
Meriem SalAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.
Narimane BerkaneAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.
Lucie AllardAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.
Camille BaudryAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.
Jean-Jacques PortalAP-HP, Unité de Recherche Clinique St-Louis-Lariboisière, Université Denis Diderot, 75009 Paris, France.
Lionel CarbillonAP-HP, Department of Obstetrics and Gynecology, Jean Verdier Hospital, Paris 13 University, Sorbonne Paris Cité, 93 000 Bondy, France.
Emmanuel CossonAP-HP, Department of Endocrinology-Diabetology-Nutrition, Avicenne Hospital, Paris 13 University, Sorbonne Paris Cité, CRNH-IdF, CINFO, 93 000 Bobigny, France.ORCID 0000-0002-8785-3385
Université Paris Cité · FRDélégation Paris 7 · FRConservatoire National des Arts et Métiers · FR

Funding

Lilly France no number
6 · The paper itself

Abstract

We aimed to evaluate each proposal of Australian-New Zealand Societies to limit the number of oral glucose tolerance tests (OGTTs) to diagnose hyperglycemia in pregnancy (HIP) during the coronavirus disease 2019 (COVID-19) pandemic. At our university hospital (2012-2016), we retrospectively applied in 4245 women who had OGTT between 22 and 30 weeks of gestation (reference standard: WHO criteria) the proposals in which OGTT is performed only in high-risk women; in all (Option 1) or high-risk (Option 1-Sel) women with fasting plasma glucose (FPG) 4.7-5.0 mmol/L; in all (Option 2) or high-risk (Option 2-Sel) women without history of HIP and with FPG 4.7-5.0 mmol/L. We also tested FPG measurement alone in all high-risk women. Measuring FPG alone had a sensitivity of 49% (95% confidence interval 45-54) applying universal screening. Option 2 appeared to have the best balance considering the needed OGTT (17.3%), sensitivity (72% (67-76)) and rates of a composite outcome (true negative cases: 10.6%, false positive cases: 24.4%; true positive cases: 19.5%; false negative cases: 10.2%). Consideration of a history of HIP and measuring first FPG can avoid more than 80% of OGTTs and identify women with the highest risk of adverse HIP-related events.

Indexed as

Australian Diabetes in Pregnancy Society (ADIPS)Australian Diabetes Society (ADS)COVID-19gestational diabetes mellitushyperglycemia in pregnancyoral glucose tolerance testpandemicpregnancy outcomesRoyal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZOG)

Identifiers

PMID33494289
PMCPMC7864504
OpenAlexW3125773766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.